BR9602719A - Virus da doença de Merek (MDV sorotipo 1) CEPA I-1585 de MDV vacina para a proteção de aves contra a doença de merek e processo para o desenvolvimento do MDV - Google Patents

Virus da doença de Merek (MDV sorotipo 1) CEPA I-1585 de MDV vacina para a proteção de aves contra a doença de merek e processo para o desenvolvimento do MDV

Info

Publication number
BR9602719A
BR9602719A BR9602719A BR9602719A BR9602719A BR 9602719 A BR9602719 A BR 9602719A BR 9602719 A BR9602719 A BR 9602719A BR 9602719 A BR9602719 A BR 9602719A BR 9602719 A BR9602719 A BR 9602719A
Authority
BR
Brazil
Prior art keywords
mdv
merek
disease
cepa
development
Prior art date
Application number
BR9602719A
Other languages
English (en)
Inventor
Hubertine Engelina Ma Spijkers
Jacob Jacobus Louwerens
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of BR9602719A publication Critical patent/BR9602719A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255Marek's disease virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16311Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR9602719A 1995-06-12 1996-06-07 Virus da doença de Merek (MDV sorotipo 1) CEPA I-1585 de MDV vacina para a proteção de aves contra a doença de merek e processo para o desenvolvimento do MDV BR9602719A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95201540 1995-06-12

Publications (1)

Publication Number Publication Date
BR9602719A true BR9602719A (pt) 1998-04-22

Family

ID=8220371

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9602719A BR9602719A (pt) 1995-06-12 1996-06-07 Virus da doença de Merek (MDV sorotipo 1) CEPA I-1585 de MDV vacina para a proteção de aves contra a doença de merek e processo para o desenvolvimento do MDV

Country Status (13)

Country Link
US (1) US5789231A (pt)
EP (1) EP0748867A1 (pt)
JP (1) JPH0998778A (pt)
CN (1) CN1147015A (pt)
AR (1) AR003003A1 (pt)
AU (1) AU5240896A (pt)
BR (1) BR9602719A (pt)
CA (1) CA2178553A1 (pt)
HU (1) HUP9601608A2 (pt)
IL (1) IL118613A0 (pt)
MX (1) MX9602256A (pt)
TR (1) TR199600502A1 (pt)
ZA (1) ZA964878B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0884382A3 (en) * 1997-06-10 2000-10-25 Pfizer Products Inc. Processes for preparation of marek's disease virus using continuous mammalian cell lines
EP1038952A3 (en) * 1998-12-09 2001-06-27 Pfizer Products Inc. Processes for preparation of Marek's Disease Virus using continuous avian cell lines
US6410222B1 (en) 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
AU2003206861B2 (en) * 2002-02-06 2009-04-23 Lohmann Animal Health Gmbh & Co. Kg A continuous cell line for the production of vaccines
FR2857671B1 (fr) * 2003-07-18 2007-10-05 Centre Nat Rech Scient Nouveau procede de culture de keratinocytes et ses applications
US20070111211A1 (en) * 2003-12-30 2007-05-17 Virumar Pituach Tarkivim Ltd. Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof
CN101365484A (zh) 2005-08-15 2009-02-11 瓦克辛公司 通过给药非复制型载体化疫苗而进行的对禽类的免疫
WO2009137146A2 (en) * 2008-02-25 2009-11-12 Baxter International Inc. Method for producing continuous cell lines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens
US4071618A (en) * 1974-09-03 1978-01-31 Research Foundation For Microbial Diseases Of Osaka University Process for preparing virus disease live vaccines
EP0015074B1 (en) * 1979-02-06 1983-07-20 Sigmund Stokland Harvester-thresher
NL8401120A (nl) * 1984-04-09 1985-11-01 Centraal Diergeneeskundig Inst Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.

Also Published As

Publication number Publication date
JPH0998778A (ja) 1997-04-15
US5789231A (en) 1998-08-04
MX9602256A (es) 1997-01-31
AR003003A1 (es) 1998-05-27
IL118613A0 (en) 1996-10-16
ZA964878B (en) 1997-01-07
HUP9601608A2 (en) 1997-03-28
CA2178553A1 (en) 1996-12-13
HU9601608D0 (en) 1996-07-29
CN1147015A (zh) 1997-04-09
AU5240896A (en) 1997-01-02
EP0748867A1 (en) 1996-12-18
TR199600502A1 (tr) 1996-12-21

Similar Documents

Publication Publication Date Title
BR9601032A (pt) Micropartícula e formulação de vacina de dose única
BR9605153A (pt) Vacina de combinação para uso na proteção de galináceos contra a doença de newcastle kit de vacinação para imunizar galináceos contra a doença de newcastle e processo para a prevenção da doença de newcastle em galináceos
BR9608405A (pt) Composto composi-Æo farmaceutica e processo para tratar um paciente que sofre de um distÚrbio fisiolÄgico
PT820270E (pt) Sistema de particulas dispersiveis para a dessensibilizacao dos dentes
PT1003478E (pt) Preparacoes aquosas de aerossol contendo macromoleculas biologicamente activas e processo para a preparacao dos respectivos aerossois
FI963281A0 (fi) Ureaasipohjainen rokote ja helicobakteeri-infektion hoito
PT850948E (pt) Derivados propiofenona e processo para a preparacao dos mesmos
BR9607157A (pt) Composição de xampu anticaspa e processo para produzir a mesma
BR9610706A (pt) Composição aquosa de branqueamento dos dentes e processo para preparar a mesma
BR9603544A (pt) Agentes para o tratamento dos cabelos
FI953915A0 (fi) Dupuytrenin taudin lievittämiseen
BR9505612A (pt) Agente e processo para a ondulação permanente dos cabelos
KR970704445A (ko) 페노티아진 및/또는 티옥산틴을 사용한 알츠하이머 병의 치료 및/또는 예방 방법(methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes
BR9403113A (pt) Agente para tratamento dos cabelos, processo para a deformação permanente dos cabelos e processo para tratamento dos cabelos
BR9600147A (pt) Purin-6-onas 2,9-DI-substituidas processo para sua preparação medicamentos e uso
BR9602719A (pt) Virus da doença de Merek (MDV sorotipo 1) CEPA I-1585 de MDV vacina para a proteção de aves contra a doença de merek e processo para o desenvolvimento do MDV
BR9612281A (pt) Processo para preparação de um 1,2-bis(aciloóxilato) e de um 3,4-diacetóxi-1-buteno
BR9610131A (pt) Agente e processo para o combate a fungos nocivos
ZA964679B (en) Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
BR9501678A (pt) Preparação e método para tratamento dos cabelos
BR9600356A (pt) Processo para o tratamento de um reservatório contendo crustáceos
BR9607264A (pt) Composto derivado do isotiuréia composição farmacêutica uso de tal composto e processo para a preparação dos mesmos
BR9700026A (pt) Processo para operar um sistema de proteç o contra roubo e sistema de proteç o contra roubo
BR9608120A (pt) Composição farmacêutica e processo para a preparação da mesma
PT94423A (pt) Processo para a preparacao de um "shampoo" para condicionamento do cabelo, contendo um componente alcool de cadeia longa

Legal Events

Date Code Title Description
PC Transfer

Free format text: DIMMINACO AG/SA/LTD (CH)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]